Novo Nordisk’s Wegovy and copyright, both run by semaglutide, have revolutionized obesity treatment as a result of unprecedented weight loss outcomes.to help adults and youngsters aged twelve decades and more mature with obesity, or some adults with overweight with weight-associated clinical troubles, reduce surplus physique weight and maintain i